Choroidal modifications assessed by means of choroidal vascularity index after oral eplerenone treatment in chronic central serous chorioretinopathy-Reference-Cited by-同舟云学术

Choroidal modifications assessed by means of choroidal vascularity index after oral eplerenone treatment in chronic central serous chorioretinopathy

Published:2022-05-19 Issue:6 Volume:37 Page:1214-1218
ISSN:0950-222X
Container-title:Eye
language:en
Short-container-title:Eye

Author:

Toto Lisa^ORCID,Ruggeri Maria Ludovica,Evangelista Federica,Viggiano Pasquale,D’Aloisio Rossella^ORCID,De Nicola Chiara,Falconio Gennaro,Di Nicola Marta,Porreca Annamaria,Mastropasqua Rodolfo

Publisher

Springer Science and Business Media LLC

Subject

Ophthalmology

Link

https://www.nature.com/articles/s41433-022-02091-6.pdf

Reference39 articles.

1. Kitzmann AS, Pulido JS, Diehl NN, Hodge DO, Burkel JP. The incidence of central serous chorioretinopathy in Olmsted County, Minnesota, 1980-2002. Ophthalmol. 2008;115:169–73.

2. Wong KH, Lau KP, Chhablani J, Tao Y, Li Q, Wong IY. Central serous chorioretinopathy: what we have learnt so far. Acta Ophtalmol. 2016;94:321–5.

3. Daruich A, Matet A, Dirani A, Gallice M, Nicholson L, Sivaprasad S, et al. Oral mineralocorticoid-receptor antagonists: real-life experience in clinical subtypes of nonresolving central serous chorioretinopathy with chronic epitheliopathy. Transl Vis Sci Technol. 2016;5:2.

4. Cheung CMG, Lee WK, Koizumi H, Dansingani K, Lai TYY, Freund KB. Pachychoroid disease. Eye(Lond). 2019;33:14–33.

5. Zhao M, Célérier I, Bousquet E, Jeanny JC, Jonet L, Savoldelli M, et al. Mineralocorticoid receptor is involved in rat and human ocular chorioretinopathy. J Clin Invest. 2012;122:2672–9.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Subthreshold Micropulse Laser Versus Oral Spironolactone in Chronic Central Serous Chorioretinopathy: A Quasi-Randomized Controlled Trial;Translational Vision Science & Technology;2024-08-12

2. Efficacy and Predictive Factors of Oral Spironolactone Treatment in Chronic Central Serous Chorioretinopathy;Journal of Ophthalmology;2024-03-18

3. Choriocapillaris Reperfusion in Resolved Chronic Central Serous Chorioretinopathy Treated with Eplerenone: Long-Term Effects on the Fellow Eye;Ophthalmology and Therapy;2023-09-25

4. Continuous Eplerenone Treatment in Chronic Central Serous Chorioretinopathy: Long-Term Results from a Pilot Study;Clinical Ophthalmology;2023-07